CORZ profile · all as-reported value updates
Core Scientific, Inc./tx (CORZ) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Net income | 2021 | -32,498,553 | 47,312,000 | 79,810,553 | +168.69% | revised comparative figure | 0001193125-22-088850 0001628280-24-010682 | 3 filed observations examined for this concept and period. |
| Stockholders' equity | 2021 | -64,209,952 | 1,341,210,000 | 1,405,419,952 | +104.79% | revised comparative figure | 0001193125-22-088850 0001628280-26-013232 | 5 filed observations examined for this concept and period. |
| Operating income | 2021 | -5,213,592 | 131,494,000 | 136,707,592 | +103.96% | revised comparative figure | 0001193125-22-088850 0001628280-24-010682 | 3 filed observations examined for this concept and period. |
| Stockholders' equity | 2020 | 14,600 | 89,224,000 | 89,209,400 | +99.98% | revised comparative figure | 0001193125-22-088850 0001628280-24-010682 | 3 filed observations examined for this concept and period. Earliest observation is a comparative value in a later annual filing. |
| Cash and cash equivalents | 2021 | 970,876 | 117,871,000 | 116,900,124 | +99.18% | revised comparative figure | 0001193125-22-088850 0001628280-24-010682 | 3 filed observations examined for this concept and period. |
| Operating cash flow | 2021 | -1,871,454 | -56,735,000 | -54,863,546 | -96.70% | revised comparative figure | 0001193125-22-088850 0001628280-24-010682 | 3 filed observations examined for this concept and period. |
| Liabilities | 2021 | 65,578,469 | 1,053,178,000 | 987,599,531 | +93.77% | revised comparative figure | 0001193125-22-088850 0001628280-23-010454 | 2 filed observations examined for this concept and period. |
| Operating income | 2024 | -19,196,000 | -142,065,000 | -122,869,000 | -86.49% | figure amended in 10-K/A | 0001628280-25-008302 0001628280-26-013305 | 3 filed observations examined for this concept and period. |
| Assets | 2021 | 346,368,517 | 2,438,864,000 | 2,092,495,483 | +85.80% | revised comparative figure | 0001193125-22-088850 0001628280-23-010454 | 2 filed observations examined for this concept and period. |
| Stockholders' equity | 2024 | -820,180,000 | -943,049,000 | -122,869,000 | -13.03% | figure amended in 10-K/A | 0001628280-25-008302 0001628280-26-013305 | 3 filed observations examined for this concept and period. |
| Net income | 2024 | -1,315,005,000 | -1,437,874,000 | -122,869,000 | -8.55% | figure amended in 10-K/A | 0001628280-25-008302 0001628280-26-013305 | 3 filed observations examined for this concept and period. |
| Assets | 2024 | 1,598,815,000 | 1,475,946,000 | -122,869,000 | -7.69% | figure amended in 10-K/A | 0001628280-25-008302 0001628280-26-013305 | 3 filed observations examined for this concept and period. |